Verano Revenue and Competitors

Chicago, IL USA

Location

N/A

Total Funding

Medical

Industry

Employee Data

  • Verano has 1085 Employees.(i)
  • Verano grew their employee count by 12% last year.

Verano's People

NameTitleEmail/Phone
1
Chief Marketing OfficerReveal Email/Phone
2
President / Chief Operating OfficerReveal Email/Phone
3
Chief Marketing OfficerReveal Email/Phone
4
VP, Kitchen ProductionReveal Email/Phone
5
VP ProcurementReveal Email/Phone
6
EVP Legal and Real Estate at Verano Holdings, LLCReveal Email/Phone
7
EVPReveal Email/Phone
8
VP, FinanceReveal Email/Phone
9
EVP CultivationReveal Email/Phone
10
VP and Associate General CounselReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A818%N/AN/A
#2
N/A9327%N/AN/A
#3
$35M767%N/AN/A
#4
N/A179-6%N/AN/A
#5
N/A5237%N/AN/A
#6
N/A108512%N/AN/A
#7
N/A359%N/AN/A
#8
$3.5M4413%N/AN/A
#9
N/A6724%N/AN/A
#10
$3.5M327%N/AN/A
Add Company

What Is Verano?

Verano™ is a national, vertically-integrated operator of licensed cannabis cultivation, manufacturing, and retail facilities dedicated to improving lives by providing safe access to effective organic cannabis products that enhance health and wellness and by positively impacting the communities it serves. Verano develops and produces a well-rounded suite of limited edition, fashion-forward cannabis products, which offer superior medicinal therapies and inspirational product options. It designs, builds, and operates unique Zen Leaf™ branded dispensary environments that ensure an exceptional shopping experience with unparalleled customer service and satisfaction in both medical and adult-use markets. Verano distributes cannabis concentrates, edibles, extracts, flower and topicals under its trusted premium brands: G-Line, Avexia™, Encore Edibles and verano™.

keywords:N/A

N/A

Total Funding

1085

Number of Employees

N/A

Revenue (est)

12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$321M1092-9%N/A
#2
$382.9M10947%N/A
#3
$445.4M10976%N/A
#4
$205.4M11004%N/A
#5
$750M11010%$366.3M